ApoB (apolipoprotein B) is a core component of atherogenic lipoproteins like LDL and VLDL. It is primarily a marker for cardiovascular risk, not directly for blood sugar. However, elevated ApoB is often part of the dyslipidemia seen in insulin resistance and type 2 diabetes (metabolic syndrome). Some evidence suggests that lowering ApoB through lifestyle changes (e.g., Mediterranean diet, exercise) may improve insulin sensitivity, but the effect on blood glucose is indirect and modest. MyBody-X includes ApoB in its advanced lipid panel. Caveat: ApoB is not a substitute for HbA1c or fasting glucose. Evidence for a direct blood-sugar benefit is human-moderate, not strong. Always consult a clinician for interpretation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d7d76a4715bc0f02a1a756ce